Unique ID issued by UMIN | UMIN000023182 |
---|---|
Receipt number | R000026725 |
Scientific Title | A phase II study of carbon-ion radiotherapy combined with anti-tumor agents for mucosal malignant melanoma of the head and neck |
Date of disclosure of the study information | 2016/08/01 |
Last modified on | 2023/12/27 09:11:24 |
A phase II study of carbon-ion radiotherapy combined with anti-tumor agents for mucosal malignant melanoma of the head and neck
Carbon-ion therapy for malignant melanoma of the head and neck (iROCK-1603HN)
A phase II study of carbon-ion radiotherapy combined with anti-tumor agents for mucosal malignant melanoma of the head and neck
Carbon-ion therapy for malignant melanoma of the head and neck (iROCK-1603HN)
Japan |
mucosal malignant melanoma of the head and neck
Oto-rhino-laryngology | Radiology |
Malignancy
NO
To evaluate the efficacy and safety of carbon-ion radiotherapy for mucosal malignant melanoma of the head and neck.
Safety,Efficacy
3-year survival rate
1) Local control rate
2) Disease-specific survival
3) Early and late adverse event rate
4) Local response rate
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
A total of 64.0 GyE of carbon-ion radiotherapy, consisting of 16 fractions of 4.0 GyE/ day for 6 to 8 times in 2 weeks
15 | years-old | <= |
80 | years-old | >= |
Male and Female
1) Mucosal malignant melanoma of head and neck which is pathologically or cytologically diagnosed
2) Patient without lymph node metastasis (N0) and no remote metastasis(M0)
3) Measurable primary lesion
4) 0 to 2 of performance status
5) 15 years or older and 80 years or younger of age
6)Sufficient organ functions
7) Patient is able to understand this clinical trial and is informed for the diagnosis and disease status. And patient can be given consent with document after explanation of this trial by study personnel
1)Patient with past history of radiotherapy for the targeted lesion
2)Patient is within 2 weeks after the final chemoterapy
3)Patient with active double cancer
4)Patients with active and intractable infection in the targeted lesion
5) Patient with metal devices in the lesion
6) Other medical or psychological condition which is unsuitable for carbon-ion therapy
65
1st name | Hiroyuki |
Middle name | |
Last name | Katoh |
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Department of Carbon-ion Radiotherapy
241-8515
2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture
045-520-2222
hkatoh@kcch.jp
1st name | Hiroyuki |
Middle name | |
Last name | Katoh |
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Ion-beam Radiation Oncology Center
241-8515
2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture
045-520-2222
hkatoh@kcch.jp
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Self funding
None
Kanagawa Cancer Center IRB
2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture
045-520-2222
clinical_trials@kcch.jp
NO
神奈川県立がんセンター(神奈川県)
2016 | Year | 08 | Month | 01 | Day |
Unpublished
2
This study confirmed safety and efficacy comparable to those reported from prior facilities.
2023 | Year | 12 | Month | 27 | Day |
Completed
2016 | Year | 03 | Month | 09 | Day |
2016 | Year | 05 | Month | 19 | Day |
2016 | Year | 08 | Month | 01 | Day |
2025 | Year | 08 | Month | 31 | Day |
2025 | Year | 08 | Month | 31 | Day |
2025 | Year | 08 | Month | 31 | Day |
2026 | Year | 08 | Month | 31 | Day |
2016 | Year | 07 | Month | 15 | Day |
2023 | Year | 12 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026725